Fidelity Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-6,751
| Closed | -$11.9K | – | 5925 |
|
2024
Q3 | $11.9K | Sell |
6,751
-3,953
| -37% | -$6.96K | ﹤0.01% | 4369 |
|
2024
Q2 | $12.5K | Buy |
10,704
+7,781
| +266% | +$9.1K | ﹤0.01% | 4247 |
|
2024
Q1 | $26.4K | Buy |
2,923
+479
| +20% | +$4.33K | ﹤0.01% | 3890 |
|
2023
Q4 | $26.6K | Sell |
2,444
-2,097
| -46% | -$22.8K | ﹤0.01% | 3800 |
|
2023
Q3 | $36.6K | Buy |
4,541
+122
| +3% | +$982 | ﹤0.01% | 3510 |
|
2023
Q2 | $48K | Sell |
4,419
-14
| -0.3% | -$152 | ﹤0.01% | 3453 |
|
2023
Q1 | $30.6K | Buy |
4,433
+4,210
| +1,888% | +$29K | ﹤0.01% | 3654 |
|
2022
Q4 | $888 | Sell |
223
-250,644
| -100% | -$998K | ﹤0.01% | 4678 |
|
2022
Q3 | $1.67M | Sell |
250,867
-228
| -0.1% | -$1.52K | ﹤0.01% | 2476 |
|
2022
Q2 | $1.22M | Sell |
251,095
-62,187
| -20% | -$301K | ﹤0.01% | 2624 |
|
2022
Q1 | $2.93M | Sell |
313,282
-97,883
| -24% | -$915K | ﹤0.01% | 2501 |
|
2021
Q4 | $4.89M | Sell |
411,165
-63,625
| -13% | -$756K | ﹤0.01% | 2371 |
|
2021
Q3 | $5.4M | Buy |
474,790
+25
| +0% | +$284 | ﹤0.01% | 2343 |
|
2021
Q2 | $8.52M | Hold |
474,765
| – | – | ﹤0.01% | 2171 |
|
2021
Q1 | $7.35M | Hold |
474,765
| – | – | ﹤0.01% | 2144 |
|
2020
Q4 | $5.79M | Buy |
474,765
+142,857
| +43% | +$1.74M | ﹤0.01% | 2143 |
|
2020
Q3 | $4.27M | Hold |
331,908
| – | – | ﹤0.01% | 2117 |
|
2020
Q2 | $3.37M | Buy |
+331,908
| New | +$3.37M | ﹤0.01% | 2164 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 4356 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 4353 |
|